Skip to main content

Table 4 Prognostic factors associated with OS and PFS in multivariate analysis

From: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis

Prognosis variables

Overall survival

Progression-free survival

p value

HR (95% CI)

p value

HR (95% CI)

Age, <60/≥60

  

0.018*

2.373 (1.162–4.847)

Number of metastasis, <3/≥3

0.781

0.843 (0.251–2.823)

0.582

1.309 (0.501–3.423)

Liver metastasis resection, yes/no

0.002*

0.003 (0.012–0.033)

0.017*

0.180 (0.058–0.554)

NLR, ≥4/<4

0.477

1.511 (0.212–2.064)

0.520

1.334 (0.312–1.801)

PLR, ≥150/<150

0.510

1.447 (0.231–2.070)

0.027*

2.591 (0.166–0.896)

LDH, normal/elevated

  

0.011*

0.310 (0.125–0.768)

  1. *A p value ≤0.05 was considered statistically significant